ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 11 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Jubilant Pharmova Business Update

Jubilant Pharmova's subsidiary Jubilant Therapeutics will present preliminary Phase 1 clinical data for JBI-802 at the 68th ASH meeting. A company event on December 14, 2026 will discuss the data.

Source

BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Jubilant Pharmova Ltd: key numbers

Share price
₹966.00
Market cap
₹15,387 Cr
Revenue (annual)
₹8,280 Cr
Net profit (annual)
₹398.5 Cr
P/E (TTM)
43.7×Sector 43.4×
Promoter holding
47.68%+0.00% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jubilant Pharmova Ltd

All →

Other business update announcements

All →